Detalles de la búsqueda
1.
Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials.
J Infect Dis
; 228(6): 715-722, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37202147
2.
Machine Learning-Based Prediction of Acute Kidney Injury Following Pediatric Cardiac Surgery: Model Development and Validation Study.
J Med Internet Res
; 25: e41142, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603200
3.
Randomised controlled trial: effect of metformin add-on therapy on functional cure in entecavir-treated patients with chronic hepatitis B.
Ann Hepatol
; 27(6): 100745, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964909
4.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Lancet
; 395(10240): 1845-1854, 2020 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32450106
5.
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 396(10249): 479-488, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32702299
6.
Novel insight from the first lung transplant of a COVID-19 patient.
Eur J Clin Invest
; 51(1): e13443, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131070
7.
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 389(10069): 621-628, 2017 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28017399
8.
Long-term efficacy of a hepatitis E vaccine.
N Engl J Med
; 372(10): 914-22, 2015 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25738667
9.
Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
Lancet
; 398(10317): 2134-2135, 2021 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34774194
10.
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.
Lancet
; 385(9984): 2272-9, 2015 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25817373
11.
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 386(10002): 1457-64, 2015 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26142048
12.
An epidemic of coxsackievirus B3 infection in infants and children in Jiangsu Province, China: a prospective cohort study.
Arch Virol
; 161(7): 1945-7, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27020571
13.
Norovirus Infection and Histo-blood Group Antigens in Children Hospitalized with Diarrhea in Lulong and Chenzhou in China.
Biomed Environ Sci
; 29(4): 286-9, 2016 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27241739
14.
Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.
J Med Virol
; 87(12): 2009-17, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26010334
15.
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
Lancet
; 381(9871): 1037-45, 2013 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23352749
16.
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 381(9882): 2024-32, 2013 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23726161
17.
Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies.
Expert Rev Vaccines
; 23(1): 419-431, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38529685
18.
Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos).
EClinicalMedicine
; 67: 102372, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38169790
19.
Toluene degradation using plasma-catalytic hybrid system over Mn-TiO2 and Fe-TiO2.
Environ Sci Pollut Res Int
; 30(9): 23494-23509, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36323971
20.
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov.
Expert Rev Vaccines
; 22(1): 704-713, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501516